Skip to main content

Peer Review reports

From: Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial

Original Submission
5 Apr 2021 Submitted Original manuscript
29 Jun 2021 Reviewed Reviewer Report - Alexander Gough
7 Nov 2021 Author responded Author comments - hugh wright
Resubmission - Version 2
7 Nov 2021 Submitted Manuscript version 2
12 Nov 2021 Reviewed Reviewer Report - Alexander Gough
20 Nov 2021 Reviewed Reviewer Report - Alain Amstutz
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Nov 2021 Editorially accepted
7 Dec 2021 Article published 10.1186/s13063-021-05870-w

You can find further information about peer review here.

Back to article page